✦ LIBER ✦

Screening for triploidy by fetal nuchal translucency and maternal serum free β-hCG and PAPP-A at 10–14 weeks of gestation

✍ Scribed by Kevin Spencer; Adolfo W. J. Liao; Hara Skentou; Simona Cicero; Kypros H. Nicolaides

Publisher: John Wiley and Sons
Year: 2000
Tongue: English
Weight: 123 KB
Volume: 20
Category: Article
ISSN: 0197-3851
DOI: 10.1002/1097-0223(200006)20:6<495::aid-pd846>3.0.co;2-u

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Screening for trisomy 18 by fetal nuchal

Screening for trisomy 18 by fetal nuchal translucency and maternal serum free β -hCG and PAPP-A at 10–14 weeks of gestation

✍ Natasha Tul; Kevin Spencer; Penelope Noble; Christine Chan; Kypros Nicolaides 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 214 KB

In a study of 50 cases of trisomy 18 compared with 947 controls we have found the median multiple of the median (MoM) of maternal serum free human chorionic gonadotrophin to be significantly decreased (0.281 MoM) in samples collected between the 10th and 14th week of gestation. Similarly, maternal s

Screening for trisomy 13 by fetal nuchal

Screening for trisomy 13 by fetal nuchal translucency and maternal serum free β-hCG and PAPP-A at 10–14 weeks of gestation

✍ Kevin Spencer; Charas Ong; Hara Skentou; Adolfo W. Liao; Kypros H. Nicolaides 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB

In 42 cases of trisomy 13 at 10±14 weeks of gestation, compared with 947 controls, the median multiple of the median (MoM) of maternal serum free b-human chorionic gonadotrophin (b-hCG) and pregnancy associated plasma protein A (PAPP-A) was signi®cantly decreased (0.506 MoM and 0.248 MoM respectivel

The influence of fetal sex in screening

The influence of fetal sex in screening for trisomy 21 by fetal nuchal translucency, maternal serum free β-hCG and PAPP-A at 10–14 weeks of gestation

✍ Kevin Spencer; Charas Y. T. Ong; Adolfo W. J. Liao; Demetres Papademetriou; Kypr 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 54 KB 👁 2 views

In a study of 2923 normal pregnancies and 203 pregnancies affected by trisomy 21 we have shown a signi®cant difference in the median MoM of the markers: fetal nuchal translucency, maternal serum free b-hCG and PAPP-A in the presence of a female fetus compared with a male fetus. For maternal serum fr

First trimester prenatal diagnosis of tr

First trimester prenatal diagnosis of trisomy 21 in discordant twins using fetal nuchal translucency thickness and maternal serum free β-hCG and PAPP-A

✍ Kevin Spencer; Kypros H. Nicolaides 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 45 KB 👁 1 views

First-trimester screening for Down syndr

First-trimester screening for Down syndrome using nuchal translucency measurement with free β-hCG and PAPP-A between 10 and 13 weeks of pregnancy—the combined test

✍ P. De Biasio; M. Siccardi; G. Volpe; L. Famularo; F. Santi; S. Canini 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 153 KB 👁 2 views

In a population of 1467 women attending the 'G. Gaslini' Institute for antenatal care, we evaluated first-trimester risk screening for Down syndrome using the 'combined test' based on ultrasound measurement of nuchal translucency (NT), maternal serum pregnancy-associated plasma protein A (PAPP-A) an